Health Highlights: Nov. 7, 2022​

• Tweet
• Pin It

Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more

Is surgery always necessary for chronic chest pain? A new clinical trial finds patients’ overall risk of death is about the same whether they choose aggressive surgical treatment or a more conservative approach focused on medication and lifestyle changes. Read more

Paxlovid might cut odds for long COVID. A new analysis showed people treated with the drug had a 26% reduced risk of developing several long COVID conditions, including heart disease, blood disorders, fatigue and other issues. Read more

Copyright © 2026 HealthDay. All rights reserved.

• Tweet
• Pin It